MicroRNA-299 targets VEGFA and inhibits the growth, chemosensitivity and invasion of human nasopharyngeal carcinoma cells.
Nasopharyngeal cancer (NC) causes significant mortality and is one of the common types of head and neck cancers (HNC). The incidence of NC is increasing at an alarming rate and therapeutic targets are lacking. This study was performed to investigate the role and therapeutic implications of miR-299 in NC. The normal nasopharyngeal cell line NP460 and the nasopharyngeal cancer cell lines CNE1, CNE2, SUNE1 and HK1 were used in the present study. qRT-PCR was used for expression analysis. MTT assay was used for cell viability assessment. Acridine orange (AO)/ethidium bromide (EB) DAPI and Annexin V/propidium iodide (PI) staining assays were used for the detection of apoptosis. Transwell assay was used for cell invasion assay. Western blot analysis was used to determine protein expression. The expression of miR-299 was significantly (up to 9-fold) decreased in NC cells. Ectopic expression of miR-299 suppressed the proliferation by promoting the apoptosis of HK1 NC cells. The percentage of apoptotic HK1 cells was 6.3% in NC and 28.3% in miR-299 mimic-transfected cells. The apoptosis promoted by miR-299 overexpression was also associated with enhancement of Bax, depletion of Bcl-2, and activation of caspases 3 and 9 in HK1 cells. The TargetScan analysis showed vascular endothelial growth factor A (VEGFA) to be the target of miR-299. Additionally, the expression of VEGFA was enhanced in all NC cells and miR-299 ectopic expression could cause suppression of the VEGFA expression in HK1 cells. Suppression of VEGFA also inhibited the proliferation of the HK1 cells, similar to that of miR-299 overexpression. The miR-299 overexpression enhanced the chemosensitivity of the HK1 cells to 5-FU and also caused a decrease in their invasion ability. miR-299 may exhibit a therapeutic implication in NC and may prove useful in NC treatment.